Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Dapagliflozin, Metformin and Physical Activity on Glucose Variability, Body Composition and Cardiovascular Risk in Pre-diabetes

Trial Profile

Effect of Dapagliflozin, Metformin and Physical Activity on Glucose Variability, Body Composition and Cardiovascular Risk in Pre-diabetes

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 30 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dapagliflozin (Primary) ; Metformin
  • Indications Prediabetic state; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms Pre-D
  • Most Recent Events

    • 22 Nov 2021 Results of an analysis assessing the process of health behavior changes following participation in a randomised controlled trial targeting prediabetes published in the Diabetic Medicine
    • 25 Sep 2020 Results assessing association of dapagliflozin, metformin and exercise with plasma glucagon concentrations in individuals with HbA 1c defined prediabetes presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
    • 16 Jun 2020 Results presented at the 80th Annual Scientific Sessions of the American Diabetes Association

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top